loader
Please Wait
Applying Filters...

Euroapi Company Header Euroapi Company Header

X

Related Intermediates: CAS 446292-08-6

Client Email Product
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 Suanfarma (1)

02 Cohance Lifesciences (2)

03 Synnat Pharma (2)

04 Valsynthese (1)

05 Aarti Pharmalabs (3)

06 Shandong Boyuan Pharmaceutical (5)

07 Actis Generics Pvt Ltd (4)

08 Aragen Life Sciences (3)

09 Cangzhou Enke Pharma-tech Co., Ltd (3)

10 Cangzhou Senary Chemical Science-tech Co., Ltd (3)

11 Chengda Pharmaceuticals (1)

12 HUNAN OUYA BIOLOGICAL CO.,LTD (2)

13 Hangzhou Longshine Bio-Tech Co.,LTD (5)

14 Indian Drugs And Chemicals (3)

15 Indian Tex Dyes Industries (5)

16 Inventys (1)

17 Kimia Biosciences (2)

18 Luna Chemicals (3)

19 Nantong Chem-land (6)

20 Omshri Labs (3)

21 Prajna Generics (1)

22 Royal Pharma (4)

23 SPC Lifesciences Pvt. Ltd (2)

24 SS Pharma (6)

25 Sandoo Pharmaceuticals and Chemcials Co.,Ltd (1)

26 Shamrock Medicaments (1)

27 Srini Pharmaceuticals (5)

28 Synaptic Labs (4)

29 Synthland Limited (2)

530-62-1
Rivaroxaban
Suanfarma founded in 1993, is a B2B life science partner committed to health & innovation by developing, ...
Suanfarma founded in 1993, is a B2B life science partner committed to health & innovation by developing, manufacturing, & distributing high-quality APIs for the pharmaceutical industry innovatively & sustainably. Backed by a robust global network of 12 strategically located local offices, we cater to the needs of over 400 active customers in 70+ countries. At Suanfarma we offer our CDMO capacity for fermentation & chemical synthesis projects, offering a One Stop Shop service with a solid track record, & which allows us to achieve success in the development, scaling, manufacturing, & commercialization of an API, either innovative or generic.
URL Supplier Web Content
161596-47-0
Rivaroxaban
Cohance Lifesciences is a leading CDMO and API platform, offering products and services across all phases...
Cohance Lifesciences is a leading CDMO and API platform, offering products and services across all phases of a molecule’s lifecycle from development to commercialzation. With our expertise in complex chemistries, we provide end-to-end CDMO services to global innovators and have delivered numerous projects from concept to commercialization over the years.As a global API player, we serve customers across nearly 60 countries with 80+ molecules backed by robust R&D, regulatory capabilities and manufacturing infrastructure. We are among the top backward integrated exporters of pellets and have strong development and manufacturing capabilities.
URL Supplier Web Content
24065-33-6
Rivaroxaban
Cohance Lifesciences is a leading CDMO and API platform, offering products and services across all phases...
Cohance Lifesciences is a leading CDMO and API platform, offering products and services across all phases of a molecule’s lifecycle from development to commercialzation. With our expertise in complex chemistries, we provide end-to-end CDMO services to global innovators and have delivered numerous projects from concept to commercialization over the years.As a global API player, we serve customers across nearly 60 countries with 80+ molecules backed by robust R&D, regulatory capabilities and manufacturing infrastructure. We are among the top backward integrated exporters of pellets and have strong development and manufacturing capabilities.
898543-06-1
Rivaroxaban
Synnat Pharma is a fast-growing pharmaceutical company dedicated to the identification, development, prod...
Synnat Pharma is a fast-growing pharmaceutical company dedicated to the identification, development, production and distribution of potent phytochemicals and botanical extracts. APIs manufactured by Synnat are used by major drug formulators worldwide. Manufacturing activities are carried out as per ICH cGMP guidelines and several conventional and modern techniques are used for the isolation, semi-synthesis and purification of its products. Synnat Pharma has a presence in semi-regulated and non-regulated markets and is now entering regulated markets.
42518-98-9
Rivaroxaban
Synnat Pharma is a fast-growing pharmaceutical company dedicated to the identification, development, prod...
Synnat Pharma is a fast-growing pharmaceutical company dedicated to the identification, development, production and distribution of potent phytochemicals and botanical extracts. APIs manufactured by Synnat are used by major drug formulators worldwide. Manufacturing activities are carried out as per ICH cGMP guidelines and several conventional and modern techniques are used for the isolation, semi-synthesis and purification of its products. Synnat Pharma has a presence in semi-regulated and non-regulated markets and is now entering regulated markets.
438056-69-0
Rivaroxaban
Valsynthese, a privately held CDMO, is a member of the SSE Group. Headquartered in Brig, Switzerland, it ...
Valsynthese, a privately held CDMO, is a member of the SSE Group. Headquartered in Brig, Switzerland, it has a broad international reach. With over a century of experience in highly hazardous and energetic chemistry, it has the expertise to develop fine chemical projects and has established the capability to produce key chemical intermediates and APIs under GMP and ISO certification. Valsynthese is regarded as one of Europe's most experienced CDMO chemical producers. It offers a variety of projects, ranging from lab procedures to tonne-scale manufacturing. It supplies its customers with high-quality products at competitive prices.
438056-69-0
Rivaroxaban
Aarti Pharmalab, earlier the pharma division of Aarti Industries, is a leading Indian manufacturer of API...
Aarti Pharmalab, earlier the pharma division of Aarti Industries, is a leading Indian manufacturer of APIs. It has dedicated facilities to manufacture HPAPIs, corticosteroids, cytotoxic & oncology products. It has 2 R&D centers & 3 cGMP plants successfully audited by the USFDA, EUGMP, EDQM, KFDA & COFEPRIS. It also offers CDMO services for generic APIs & NCEs, intermediates & key building blocks.

Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.

Aarti Industries Company Banner

IPS 2024

Not Confirmed

envelop Contact Supplier
161596-47-0
Rivaroxaban
Aarti Pharmalab, earlier the pharma division of Aarti Industries, is a leading Indian manufacturer of API...
Aarti Pharmalab, earlier the pharma division of Aarti Industries, is a leading Indian manufacturer of APIs. It has dedicated facilities to manufacture HPAPIs, corticosteroids, cytotoxic & oncology products. It has 2 R&D centers & 3 cGMP plants successfully audited by the USFDA, EUGMP, EDQM, KFDA & COFEPRIS. It also offers CDMO services for generic APIs & NCEs, intermediates & key building blocks.

Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.

Aarti Industries Company Banner

IPS 2024

Not Confirmed

envelop Contact Supplier
24065-33-6
Rivaroxaban
Aarti Pharmalab, earlier the pharma division of Aarti Industries, is a leading Indian manufacturer of API...
Aarti Pharmalab, earlier the pharma division of Aarti Industries, is a leading Indian manufacturer of APIs. It has dedicated facilities to manufacture HPAPIs, corticosteroids, cytotoxic & oncology products. It has 2 R&D centers & 3 cGMP plants successfully audited by the USFDA, EUGMP, EDQM, KFDA & COFEPRIS. It also offers CDMO services for generic APIs & NCEs, intermediates & key building blocks.

Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.

Aarti Industries Company Banner

IPS 2024

Not Confirmed

envelop Contact Supplier
438056-69-0
Rivaroxaban
We are one of the well-known manufacturers of key APIs & intermediates in China, with 20 years of experie...
We are one of the well-known manufacturers of key APIs & intermediates in China, with 20 years of experience & presence in 20+ countries. At Boyuan, we are committed to providing high-quality products & services. Formerly known as “Jinan Boyuan Chemical Co., Ltd” & “Shandong Boyuan Chemical Co., Ltd.” Boyuan was founded in June 2001. We have 2 manufacturing plants in the cities of Jiyang & Yucheng in Shandong Province, China & both are in line with the GMP standard, following a strict quality system & conforming with international standards. Boyuan is dedicated to anti-cancer, anti-fungal & other APIs & intermediates associated.
Shandong Boyuan Pharmaceutical

IPS 2024

Not Confirmed

envelop Contact Supplier
Post Enquiry
POST ENQUIRY